Biochemical response to interferon therapy correlates with interferon sensitivity-determining region in hepatitis C virus genotype 1b infection (Q43795947)

From Wikidata

Jump to navigation Jump to search

scientific article published in November 2001

Language	Label	Description	Also known as
English	Biochemical response to interferon therapy correlates with interferon sensitivity-determining region in hepatitis C virus genotype 1b infection	scientific article published in November 2001

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Biochemical response to interferon therapy correlates with interferon sensitivity-determining region in hepatitis C virus genotype 1b infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

author name string

Yoshioka K

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Kobayashi M

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Orito E

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Watanabe K

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Yano M

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sameshima Y

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Kusakabe A

7

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Hirofuji H

8

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Fuji A

9

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Kuriki J

10

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Arao M

11

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Murase K

12

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Mizokami M

13

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Kakumu S

14

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

publication date

1 November 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

421-429

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Clinical outcomes after transfusion-associated hepatitis C.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Long-term carriage of hepatitis C virus with normal aminotransferase after interferon treatment in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

The prognostic relevance of the nonstructural 5A gene interferon sensitivity determining region is different in infections with genotype 1b and 3a isolates of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

HCV NS5A mutations in Europeans infected by genotype 1b.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

The "interferon sensitivity determining region" of hepatitis C virus is a stable sequence element

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Randomized controlled trial of lymphoblastoid interferon alpha for chronic hepatitis C (comparison of 9-MU and 6-MU doses). IFN Treatment Group of Affiliated Hospitals of the Third Department of Internal Medicine at Nagoya University School of Medic

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Classification of chronic hepatitis: diagnosis, grading and staging

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Full-length sequence of the genome of hepatitis C virus type 3a: comparative study with different genotypes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with clinical response

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00323.X

21 January 2018

Identifiers

10.1046/J.1365-2893.2001.00323.X

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43795947&oldid=2170533842"